Prevalence and Factors Affecting Willingness to Accept or Refuse Vaccination against COVID-19 among Healthcare Professionals in Southern Tunisia

Baklouti, Mouna; Ayed, H. Ben; Maamri, H.; Ketata, N.; Yaich, S.; Karray, R.; Jdidi, J.; Mejdoub, Yosra; Kassis, Mondher; Féki, H.; Dammak, Jamel

doi:10.1080/00185868.2022.2111287

Cited by 2 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…From a clinical aspect, it has been shown that this vaccine doesn't affect performance and implantation in assisted reproductive cycles following vaccination [26,27]. However, despite those studies, low compliance to the vaccine peruse [10,[28][29][30]. The impetus for this study came about due to the persistent misinformation and rumors widely disseminated on social media about the effects of the BNT162b2 vaccine on women's fertility.…”

Section: Discussionmentioning

confidence: 96%

BNT162b2 COVID-19 Vaccine has no Adverse Effect on Women’s In Vitro Fertilization Outcomes and Fertility

Safrai¹,

Rottenstreich²,

Herzberg³

et al. 2022

austiniobstetgynecol

View full text Add to dashboard Cite

Purpose: To investigate the effect of BNT162b2 COVID-19 vaccine on women’s fertility. Methods: We prospectively collected data of women patients undergoing In Vitro Fertilization (IVF) treatment after completion of 2 doses of BNT162b2 vaccination between February and April 2021 (POST vaccine). For comparison, we reviewed records of the same patients before the vaccination (PRE vaccine) up to February 2019. Each woman served as self-control before and after vaccination. Study outcomes were compared between the PRE- and POSTvaccination groups. Clinical pregnancy values were assessed if data were available for both cycles. Results: 47 women were eligible, with a mean interval of 362 ± 368 days between the two ovum pick-ups. The numbers of oocytes retrieved, matured oocytes, fertilization rates, and numbers and qualities of embryos at day 3 before-and-after vaccinations were similar for all parameters. The numbers and percentages of clinical pregnancies did not differ significantly between the two vaccination groups. Conclusion: From our findings, the vaccine does not affect women’s in vitro outcomes and, therefore, fertility. This study repudiates misinformation from unreliable sources, reassuring patients to improve compliance and promote COVID-19 eradication.

show abstract

Section: Discussionmentioning

confidence: 96%

BNT162b2 COVID-19 Vaccine has no Adverse Effect on Women’s In Vitro Fertilization Outcomes and Fertility

Safrai¹,

Rottenstreich²,

Herzberg³

et al. 2022

austiniobstetgynecol

View full text Add to dashboard Cite

show abstract

Hesitancy toward vaccination against COVID-19: A scoping review of prevalence and associated factors in the Arab world

Alam,

Mohamed,

Nauman

et al. 2023

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Despite widespread availability of vaccines against SARS-CoV-2 virus, the cause of Coronavirus Disease 2019 (COVID-19), its uptake in many Arab countries is relatively low. This literature review aimed to scope evidence on COVID-19 vaccine hesitancy (VH) in the Arab world. A total of 134 articles reporting prevalence of COVID-19 VH and associated factors, conducted in any of the 22 Arab League countries, were reviewed. COVID-19 VH prevalence ranged from 5.4% to 83.0%. Female gender, young age, low education level and lack of previous influenza vaccine uptake were most commonly reported to be associated with COVID-19 VH. The most-reported personal concerns contributing toward VH were related to the rapid development, safety and side effects of vaccine, as well as an overall lack of trust in government policies toward pandemic control and widespread conspiracy theories. Tailored interventions to enable the distribution of trusted information and enhance public acceptance of immunization are warranted.

show abstract

Prevalence and Factors Affecting Willingness to Accept or Refuse Vaccination against COVID-19 among Healthcare Professionals in Southern Tunisia

Cited by 2 publications

References 20 publications

BNT162b2 COVID-19 Vaccine has no Adverse Effect on Women’s In Vitro Fertilization Outcomes and Fertility

BNT162b2 COVID-19 Vaccine has no Adverse Effect on Women’s In Vitro Fertilization Outcomes and Fertility

Hesitancy toward vaccination against COVID-19: A scoping review of prevalence and associated factors in the Arab world

Contact Info

Product

Resources

About